APIs Active Pharmaceutical Ingredients

Quality Active Pharmaceutical Ingredients Pure Gefapixant Citrate Powder CAS 2310299-91-1 Assay 99% factory

Active Pharmaceutical Ingredients Pure Gefapixant Citrate Powder CAS 2310299-91-1 Assay 99%

Chemicals Pure Gefapixant Citrate CAS 2310299-91-1 assay 99% Grade Standard Medicine Grade Type Chemicals State Solid Volatile Not Volatile Color White Powder Assay More Than 99% Transport Package Cardboard Drums or Cartons Specification gram, kilogram Trademark Bovita Origin China HS Code 2934999099 Production Capacity 50kg/Month Powder:1kg Aluminum Foil Bag 25kg drum/bag OEM&ODM for product packaging is accepted. 1. ≤50kg, Express delivery recommended, usually called as DDU

Quality GMP Standard CAS 66104-23-2 Pergolide Mesylate Salt Raw Powder Pergolide factory

GMP Standard CAS 66104-23-2 Pergolide Mesylate Salt Raw Powder Pergolide

CAS 66104-23-2 Pergolide Mesylate Salt Raw Powder Aspect Details Product Name Pergolide mesylate salt CAS Number 66104-23-2 Chemical Formula C20H30N2O3S2 Appearance White powder Grade Medical grade Purity 99% Test Method HPLC Model NO. Pergolide mesylate salt Customized Non-Customized Certification ISO 9001, USP Suitable for Adult State Solid Purity >99% Stock in Stock Documents COA, MSDS MOQ 1gram CAS 66104-23-2 Appearance White Powder Transport Package Box/Drum Specificatio

Quality API Ingredients 99% Anti HCV API Sofosbuvir Crystalline Powder CAS 1190307-88-0 factory

API Ingredients 99% Anti HCV API Sofosbuvir Crystalline Powder CAS 1190307-88-0

Antiviral API Sofosbuvir Powder CAS 1190307-88-0 Psi-7977 for HCV Treatment Sofosbuvir is a direct-acting antiviral (DAA) nucleotide analog inhibitor that targets the hepatitis C virus (HCV) RNA polymerase. It is a cornerstone of modern HCV treatment, enabling high cure rates with all-oral, interferon-free regimens. Product Parameters Parameter Item Description English Name Sofosbuvir Category Direct-acting antiviral Appearence White to off-white crystalline powder Molecular

Previous
Page 4 of 4
Next